-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on BrightSpring Health, Raises Price Target to $80

Benzinga·07/14/2026 12:42:51
Listen to the news
Morgan Stanley analyst Erin Wright maintains BrightSpring Health (NASDAQ:BTSG) with a Overweight and raises the price target from $71 to $80.